Eos Focused Equity Management, L.P. Nevro Corp Transaction History

Eos Focused Equity Management, L.P.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 02, 2022	SELL	$81.07 - $121.29 $868,502 - $1.3 Million	-10,713 Closed	0 $0
Q3 2021 Oct 29, 2021	SELL	$101.99 - $166.36 $1.33 Million - $2.17 Million	-13,016 Reduced 54.85%	10,713 $1.25 Million
Q2 2021 Aug 02, 2021	SELL	$141.6 - $179.06 $199,656 - $252,474	-1,410 Reduced 5.61%	23,729 $3.93 Million
Q1 2021 Apr 29, 2021	BUY	$132.81 - $182.18 $1.48 Million - $2.03 Million	11,137 Added 79.54%	25,139 $3.51 Million
Q4 2020 Feb 02, 2021	BUY	$138.17 - $184.34 $263,075 - $350,983	1,904 Added 15.74%	14,002 $2.42 Million
Q3 2020 Oct 27, 2020	BUY	$114.09 - $145.51 $1.38 Million - $1.76 Million	12,098 New	12,098 $1.69 Million

163

38M

44K

1.69M

Ticker NVRO
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 35,387,800
Market Cap $196M
Description
Nevro Corp., a medical device company, provides products for patients suffering from chronic pain in the United States and internationally. The company develops and commercializes the Senza spinal cord stimulation system, an evidence-based neuromodulation platform for the treatment of chronic pain, as well as Senza II and Senza Omnia systems. It...

Get notified when there are updates to the investment portfolio of Eos Focused Equity Management, L.P., based on Form 13F filings with the SEC.

Stay updated on Eos Focused Equity Management, L.P. with notifications on news.